Order through Avantor/VWR: Box of 25
Product Overview
The Instanosis Fentanyl Harm Reduction Test Strip is an ultra-sensitive, rapid lateral flow immunoassay developed with NIH funding and manufactured in the USA for forensic and public health applications. Featuring an industry-leading analytical detection cut-off of 2 ng/mL, this standalone test strip accurately identifies fentanyl and major analogs within complex street drug matrices. Optimized for exceptional sample preservation, it requires less than 1/10th of the sample amount demanded by standard market alternative test strips. It delivers qualitative visual results within 5 minutes to support community harm reduction networks, forensic investigations, and laboratory screening.
Technical Specifications & Key Data
This standalone immunoassay strip provides specialized analytical performance parameters engineered to detect trace synthetic opioids with high reliability:
-
Target Analyte: Fentanyl core structure (with broad cross-reactivity optimization for lethal analogs including fluorofentanyl, parafluorofentanyl, crotonylfentanyl, acetylfentanyl, and butyrylfentanyl).
-
Analytical Limit of Detection (LOD): 2 ng/mL (calibrated to provide maximum sensitivity and eliminate the high false-negative rates found in low-grade field tests).
-
Micro-Volume Processing: Requires 90% less sample amount (1/10th of competitive baseline requirements), keeping primary forensic or research compounds intact for confirmatory laboratory analysis.
-
Assay Performance Window: Clear, reliable qualitative visual results in 5 minutes.
-
Quality & Funding Benchmarks: Formulated and manufactured under rigorous FDA QMSR quality standards utilizing competitive research allocations from the National Institutes of Health (NIH) and proudly Made in the U.S.
Public Health & Toxicological Significance
Illicitly manufactured fentanyl remains the primary driver of fatal overdoses globally, frequently appearing as an unlisted, highly lethal adulterant across the entire illicit supply chain.
-
Extreme Lethality Threshold: A microscopic dose of pure fentanyl as small as a few milligrams can be fatal depending on an individual’s body size and tolerance.
-
Polysubstance Contamination: Fentanyl is routinely mixed into non-opioid supplies, including cocaine, methamphetamine, and counterfeit prescription pills, making widespread harm reduction screening essential for non-opioid users.
-
Early Detection Utility: High-sensitivity lateral flow test strips act as a critical frontline defense, enabling harm reduction programs and individuals to successfully verify supply composition prior to exposure.
Ordering Options & Channel Availability
-
SKU: FENT24
-
Packaging Configurations: Available in boxes of 25 strips or bulk kits of 100 strips (each testing strip is individually sealed in a moisture-impermeable foil pouch with an active desiccant to guarantee maximum field shelf-life and stability).
-
Institutional Procurement: Municipal, state health departments or university research labs may order from this website or through primary scientific distribution catalogs Avantor / VWR (link above Product Overview).
Frequently Asked Questions (FAQ)
-
Q1: What is the exact analytical cut-off level for the Instanosis Fentanyl test strip?
A: The technical limit of detection (LOD) is calibrated at an ultra-sensitive 2 ng/mL. This exceptionally low threshold ensures high-affinity detection of fentanyl and its structural analogs even when present in highly diluted solutions or trace amounts.
-
Q2: How much sample volume is required to run a test?
A: Our advanced immunoassay design requires 1/10th of the sample amount typically required by legacy testing strips. This micro-volume format allows forensic technicians and public health researchers to maximize sample preservation.
-
Q3: Can this test strip detect other synthetic opioid analogs?
A: Yes. The immunoassay matrix is specifically optimized to provide broad cross-reactivity across the synthetic opioid family, successfully identifying highly potent analogs such as fluorofentanyl, parafluorofentanyl, crotonylfentanyl, acetylfentanyl, butyrylfentanyland and others.
-
Q4: Is this harm reduction product manufactured in the United States?
A: Yes. The Instanosis Fentanyl test strip is entirely developed and manufactured in the USA, and its development was funded by the National Institutes of Health (NIH).
-
Q5: Can public health departments buy this item through major scientific distributors?
A: Yes. In addition to direct corporate accounts, municipal health agencies and academic laboratories can procure the Instanosis Box of 25 strips using our verified distribution listings on major networks such as Avantor/VWR (link above Product Overview).
-
Q6: Is this product intended for clinical point-of-care patient diagnostics?
A: No. This product is strictly designed, labeled, and distributed for forensic investigations, harm reduction public health surveillance, and laboratory research applications only.


Click to download Instanosis fentanyl test strip instruction






